Replies to post #319924 on Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

please face the problem IV B preinfection benefits touted by RBL and Leo will not help all those already infected lung cells - with a virus that kills people mostly by destroying lung function

The trial will very likely fail given what we have been told- almost nothing really, but there has be no excitement about killing the virus in infected cells.

Wrong trial population=very likely failure B for c based on current info from IP